BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 20519625)

  • 1. Human gammadelta T lymphocytes induce robust NK cell-mediated antitumor cytotoxicity through CD137 engagement.
    Maniar A; Zhang X; Lin W; Gastman BR; Pauza CD; Strome SE; Chapoval AI
    Blood; 2010 Sep; 116(10):1726-33. PubMed ID: 20519625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer immunotherapy using a bispecific NK receptor fusion protein that engages both T cells and tumor cells.
    Zhang T; Sentman CL
    Cancer Res; 2011 Mar; 71(6):2066-76. PubMed ID: 21282338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical-grade ex vivo-expanded human natural killer cells up-regulate activating receptors and death receptor ligands and have enhanced cytolytic activity against tumor cells.
    Berg M; Lundqvist A; McCoy P; Samsel L; Fan Y; Tawab A; Childs R
    Cytotherapy; 2009; 11(3):341-55. PubMed ID: 19308771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel inhibitor of proteasome deubiquitinating activity renders tumor cells sensitive to TRAIL-mediated apoptosis by natural killer cells and T cells.
    Sarhan D; Wennerberg E; D'Arcy P; Gurajada D; Linder S; Lundqvist A
    Cancer Immunol Immunother; 2013 Aug; 62(8):1359-68. PubMed ID: 23689729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histamine modulates γδ-T lymphocyte migration and cytotoxicity, via Gi and Gs protein-coupled signalling pathways.
    Truta-Feles K; Lagadari M; Lehmann K; Berod L; Cubillos S; Piehler S; Herouy Y; Barz D; Kamradt T; Maghazachi A; Norgauer J
    Br J Pharmacol; 2010 Nov; 161(6):1291-300. PubMed ID: 20977468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activated gammadelta T cells express the natural cytotoxicity receptor natural killer p 44 and show cytotoxic activity against myeloma cells.
    von Lilienfeld-Toal M; Nattermann J; Feldmann G; Sievers E; Frank S; Strehl J; Schmidt-Wolf IG
    Clin Exp Immunol; 2006 Jun; 144(3):528-33. PubMed ID: 16734623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 4-1BB regulates NKG2D costimulation in human cord blood CD8+ T cells.
    Kim YJ; Han MK; Broxmeyer HE
    Blood; 2008 Feb; 111(3):1378-86. PubMed ID: 18024793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expansion of cytotoxic natural killer cells in multiple myeloma patients using K562 cells expressing OX40 ligand and membrane-bound IL-18 and IL-21.
    Thangaraj JL; Phan MT; Kweon S; Kim J; Lee JM; Hwang I; Park J; Doh J; Lee SH; Vo MC; Chu TH; Song GY; Ahn SY; Jung SH; Kim HJ; Cho D; Lee JJ
    Cancer Immunol Immunother; 2022 Mar; 71(3):613-625. PubMed ID: 34282497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The safety of allogeneic innate lymphocyte therapy for glioma patients with prior cranial irradiation.
    Pereboeva L; Harkins L; Wong S; Lamb LS
    Cancer Immunol Immunother; 2015 May; 64(5):551-62. PubMed ID: 25676710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bayesian approach to model CD137 signaling in human M. tuberculosis in vitro responses.
    Fernández Do Porto DA; Auzmendi J; Peña D; García VE; Moffatt L
    PLoS One; 2013; 8(2):e55987. PubMed ID: 23437083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-33 is a Novel Immunosuppressor that Protects Cancer Cells from TIL Killing by a Macrophage-Mediated Shedding Mechanism.
    Wu J; Chen Z; Wickström SL; Gao J; He X; Jing X; Wu J; Du Q; Yang M; Chen Y; Zhang D; Yin X; Guo Z; Jensen L; Yang Y; Tao W; Lundqvist A; Kiessling R; Cao Y
    Adv Sci (Weinh); 2021 Nov; 8(21):e2101029. PubMed ID: 34486239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD137 stimulation and p38 MAPK inhibition improve reactivity in an in vitro model of glioblastoma immunotherapy.
    Kühnöl C; Herbarth M; Föll J; Staege MS; Kramm C
    Cancer Immunol Immunother; 2013 Dec; 62(12):1797-809. PubMed ID: 24129764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Hedgehog inhibitor cyclopamine impairs the benefits of immunotherapy with activated T and NK lymphocytes derived from patients with advanced cancer.
    Onishi H; Morisaki T; Kiyota A; Koya N; Tanaka H; Umebayashi M; Katano M
    Cancer Immunol Immunother; 2013 Jun; 62(6):1029-39. PubMed ID: 23591983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic modification of primary natural killer cells overcomes inhibitory signals and induces specific killing of leukemic cells.
    Imai C; Iwamoto S; Campana D
    Blood; 2005 Jul; 106(1):376-83. PubMed ID: 15755898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-invasive image-based cytometry for high throughput NK cell cytolysis analysis.
    Patel RS; Lucas J; Timmins LM; Mukundan S; Teryek M; Bhatt R; Beaulieu A; Parekkadan B
    J Immunol Methods; 2021 Apr; 491():112992. PubMed ID: 33577777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Folate-conjugated immunoglobulin targets melanoma tumor cells for NK cell effector functions.
    Skinner CC; McMichael EL; Jaime-Ramirez AC; Abrams ZB; Lee RJ; Carson WE
    Melanoma Res; 2016 Aug; 26(4):329-37. PubMed ID: 27035691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The immunoglobulin superfamily ligand B7H6 subjects T cell responses to NK cell surveillance.
    Kilian M; Friedrich MJ; Lu KH; Vonhören D; Jansky S; Michel J; Keib A; Stange S; Hackert N; Kehl N; Hahn M; Habel A; Jung S; Jähne K; Sahm F; Betge J; Cerwenka A; Westermann F; Dreger P; Raab MS; Meindl-Beinker NM; Ebert M; Bunse L; Müller-Tidow C; Schmitt M; Platten M
    Sci Immunol; 2024 May; 9(95):eadj7970. PubMed ID: 38701193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrated immune responses to infection - cross-talk between human gammadelta T cells and dendritic cells.
    Eberl M; Jomaa H; Hayday AC
    Immunology; 2004 Jul; 112(3):364-8. PubMed ID: 15196203
    [No Abstract]   [Full Text] [Related]  

  • 19. Epigenetic modulation of immune synaptic-cytoskeletal networks potentiates γδ T cell-mediated cytotoxicity in lung cancer.
    Weng RR; Lu HH; Lin CT; Fan CC; Lin RS; Huang TC; Lin SY; Huang YJ; Juan YH; Wu YC; Hung ZC; Liu C; Lin XH; Hsieh WC; Chiu TY; Liao JC; Chiu YL; Chen SY; Yu CJ; Tsai HC
    Nat Commun; 2021 Apr; 12(1):2163. PubMed ID: 33846331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plant lectin, ATF1011, on the tumor cell surface augments tumor-specific immunity through activation of T cells specific for the lectin.
    Yoshimoto R; Kondoh N; Isawa M; Hamuro J
    Cancer Immunol Immunother; 1987; 25(1):25-30. PubMed ID: 3496156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.